tirzepatide once weekly for the treatment of obesity journal club Obesity: “Mounting” Evidence for Substantial Weight Loss VisualAbstract: Once-weekly tirzepatide significantly improves

Organizations that cover GLP-1 drugs for weight loss typically do so through one of three ways: a prescription drug within a medical plan (85%), a dedicated weight management vendor point solution (12%) or a supplemental drug rider (4%)

Fertility Weight Has Long Been A Barrier To IVF

C.ShaoS

Evidence varies substantially between countries and populations, reflecting differences in study design, reporting practices, legal frameworks, and cultural attitudes toward anabolicandrogenic substance use

Clinical studies have demonstrated significant improvements in glycemic control and weight management

Both medications work in similar ways and affect the GLP-1 hormone in the body